Federal patent changes to add new costs to drug plans, report predicts
New federal legislation around pharmaceutical patents will impose significant costs on public and private drug plans, the parliamentary budget officer is predicting. The legislation would…
- By: Sara Tatelman
- May 3, 2018 September 13, 2019
- 08:30